Effect of L-Carnitine Supplementation in Preterm Neonates

Recruiting now · Not applicable

Conditions studied: Respiratory Distress Syndrome

In brief

The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.

Key facts

Study ID

NCT07437391

Run by

Muhammad Aamir Latif

People needed

160

Starts

2026-01-01

Expected to finish

2026-06-30

Last updated by the study team

2026-02-27

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Preterm neonates
• Either gender
• With RDS
• Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth .

You may not qualify if…

• Neonates with gastrointestinal tract (GIT) anomalies
• With confirmed or suspected sepsis at the time of enrollment
• Neonates whose clinical condition contraindicates study participation (e.g., expected survival <48 hours, as judged by the neonatologist).

Where it is running

• Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network — Muzaffargarh, Punjab Province, Pakistan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.